ZwickRoell is excited to announce a groundbreaking strategy in the rapidly expanding field of pharmaceutical and medical device testing equipment and services with the introduction
MaxisIT, a long-recognized provider of clinical data analytics platform for clinical trials, announced its transformation into Maxis AI. This strategic evolution is marked by the introduction
Outperforming NAD+ IV, Niagen IV (patented nicotinamide riboside or NR) provides superior tolerability, a 75% shorter infusion time, and increases NAD+ 20% higher three hours
Virgo Surgical Video Solutions, Inc., a leader in endoscopic AI technologies, announced the official launch of EndoML at Digestive Disease Week (DDW) 2025. EndoML is
Recently, seven Chinese regulatory bodies including the Ministry of Industry and Information Technology , the National Health Commission, the Ministry of Commerce, and other key
This major acquisition in Ticino will allow the two companies to combine their forces of production, chemical and biological expertise, know-how and technological capabilities, creating
CAR T-cell Therapy Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain CAR T-cell therapy is revolutionizing
AI users in healthcare see significant opportunities in using unstructured data for innovation and predictive modeling, but less than half are fully satisfied with their
CJ Bioscience announced that it will present preclinical data on its novel drug candidate CJRB-201 at the European Crohn’s and Colitis Organization (ECCO) 2025, set to take
FLEX MARKETING, a dynamic new independent agency built to modernize the approach to healthcare marketing. Its agile, innovative model is ideally suited to address the
Apotex, the largest Canadian-based pharmaceutical company, announced a grant through the Apotex Global Health Access Fund to Healthy Mothers, Healthy Babies Coalition of Broward County in Lauderhill,
Evofem Biosciences, announced that the United States Patent and Trademark Office (USPTO) issued to the Company a Notice of Allowance for patent application 17/028,838, entitled
